1. The impact of subspecialty training on the management of advanced ovarian cancer
2. Hoskins WJ, McGuire WP, Brady MF, The effect of diameter 32. Skipper HE. Adjuvant chemotherapy. Cancer 1978; 41:936-940. of largest residual disease on survival after primary cytoreduc- 33. Skipper HE. Thoughts on cancer chemotherapy and combination tive surgery in patients with suboptimal residual epithelial ovar- modality therapy. JAMA 1974; 230:1033-1035. ian carcinoma.Am J Obstet Gynecol 1994; 170:974-979. 34. Bookman MA, Berek JS. Biologic and immunologic therapy of
3. Biologic and Immunologic Therapy of Ovarian Cancer